Xoma reported $4.82M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Agenus AGEN:US USD 64.42M 1.07M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Ardelyx ARDX:US USD 26.87M 1.88M
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
Chimerix CMRX:US USD 20.91M 2.98M
Curis CRIS:US USD 15.43M 2.02M
Eli Lilly And LLY:US USD 5.27B 12.8M
Emergent Biosolutions EBS:US USD 282M 32.7M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Life Technologies LIFE:US USD 13.49M 908K
Macrogenics MGNX:US USD 66.69M 1.13M
Novartis NOVN:VX USD 10.67B 183M
Novartis NVS:US USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Prothena PRTA:US USD 51.85M 7.33M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
Xoma XOMA:US USD 4.82M 927K
YTE INCY:US USD 684.93M 27.96M